{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:25:08Z","timestamp":1782487508170,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.jaad.2008.06.029","type":"journal-article","created":{"date-parts":[[2008,10,17]],"date-time":"2008-10-17T05:28:47Z","timestamp":1224221327000},"page":"S80-S83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"S","title":["Imatinib mesylate\u2013induced repigmentation of vitiligo lesions in a patient with recurrent gastrointestinal stromal tumors"],"prefix":"10.1016","volume":"59","author":[{"given":"Hui","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2008.06.029_bib1","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.ejca.2005.09.009","article-title":"Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study","volume":"41","author":"Goettsch","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2008.06.029_bib2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/cncr.20862","article-title":"Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era\u2014a population-based study in western Sweden","volume":"103","author":"Nilsson","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2008.06.029_bib3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jaad.2008.06.029_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pai.0000173054.83414.22","article-title":"KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation","volume":"13","author":"Miettinen","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.jaad.2008.06.029_bib5","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1200\/JCO.2004.05.140","article-title":"Biology of gastrointestinal stromal tumors","volume":"22","author":"Corless","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2008.06.029_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s004410050859","article-title":"Ultrastructural identification of the c-kit-expressing interstitial cells in the rat stomach: a comparison of control and Ws\/Ws mutant rats","volume":"289","author":"Ishikawa","year":"1997","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jaad.2008.06.029_bib7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1101\/gad.3.6.816","article-title":"Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice\u2014evidence for an impaired c-kit kinase in mutant mice","volume":"3","author":"Nocka","year":"1989","journal-title":"Genes Dev"},{"key":"10.1016\/j.jaad.2008.06.029_bib8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.V80.2.374.374","article-title":"Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors","volume":"80","author":"Turner","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2008.06.029_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","article-title":"Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors","volume":"295","author":"Buchdunger","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2008.06.029_bib10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.06.029_bib11","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1158\/1078-0432.CCR-05-2275","article-title":"Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate","volume":"12","author":"Prenen","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2008.06.029_bib12","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.06.029_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.06.029_bib14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/gast.2001.20880","article-title":"Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germline mutation of the c-kit gene","volume":"120","author":"Maeyama","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaad.2008.06.029_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ajmg.a.30388","article-title":"Novel c-KIT germline mutation in a family with gastrointestinal stromal tumors and cutaneous hyperpigmentation","volume":"132","author":"Carballo","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jaad.2008.06.029_bib16","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1158\/1078-0432.CCR-03-0110","article-title":"Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia","volume":"10","author":"Robson","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2008.06.029_bib17","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2005.06.009","article-title":"Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred","volume":"23","author":"Li","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2008.06.029_bib18","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s00018-004-4189-6","article-title":"Signal transduction via the stem cell factor receptor\/c-Kit","volume":"61","author":"Ronnstrand","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaad.2008.06.029_bib19","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/sj.jid.5700125","article-title":"Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes","volume":"126","author":"Alexeev","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2008.06.029_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/335088a0","article-title":"The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus","volume":"335","author":"Chabot","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2008.06.029_bib21","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0749.1992.tb00559.x","article-title":"The molecular basis of human piebaldism","volume":"5","author":"Spritz","year":"1992","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jaad.2008.06.029_bib22","doi-asserted-by":"crossref","first-page":"10885","DOI":"10.1073\/pnas.88.23.10885","article-title":"Deletion of the c-kit protooncogene in the human developmental defect piebald trait","volume":"88","author":"Fleischman","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2008.06.029_bib23","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jama.293.6.730","article-title":"New insights and new therapies in vitiligo","volume":"293","author":"Grimes","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2008.06.029_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/path.1538","article-title":"Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF\/KIT protein interactions and the downstream effector, MITF-M","volume":"202","author":"Kitamura","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.jaad.2008.06.029_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2133.1996.tb07618.x","article-title":"The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo","volume":"134","author":"Norris","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.06.029_bib26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2133.1995.tb05011.x","article-title":"Expression of the c-kit receptor in hypomelanosis: a comparative study between piebaldism, naevus depigmentosus and vitiligo","volume":"132","author":"Dippel","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.06.029_bib27","first-page":"372","article-title":"Open trial of topical tacalcitol [1 alpha 24(OH)2D3] and solar irradiation for vitiligo vulgaris: upregulation of c-Kit mRNA by cultured melanocytes","volume":"13","author":"Katayama","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2008.06.029_bib28","first-page":"939","article-title":"Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression","volume":"10","author":"Montone","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaad.2008.06.029_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9250","article-title":"Imatinib for the treatment of patients with unresectable and\/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation","volume":"9","author":"Wilson","year":"2005","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jaad.2008.06.029_bib30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM200108233450814","article-title":"Cutaneous reactions to STI571","volume":"345","author":"Brouard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.06.029_bib31","first-page":"228","article-title":"Imatinib mesylate and dermatology. Part 2: a review of the cutaneous side effects of imatinib mesylate","volume":"5","author":"Scheinfeld","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2008.06.029_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/0253-7613.19860","article-title":"Imatinib mesylate-induced generalized hypomentation in patients with chronic myeloid leukemia","volume":"38","author":"Sunita","year":"2006","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jaad.2008.06.029_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1525-1470.2006.00208.x","article-title":"Vitiligo-like lesions and diffuse lightening of the skin in a pediatric patient treated with imatinib mesylate: a noninvasive colorimetric assessment","volume":"23","author":"Brazzelli","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2008.06.029_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0378-6323.13788","article-title":"Generalized hypopigmentation due to imatinib: a fairness boon?","volume":"71","author":"Sharma","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2008.06.029_bib35","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2141.2005.05431.x","article-title":"Loss of skin pigment caused by imatinib therapy","volume":"129","author":"McPartlin","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2008.06.029_bib36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2133.2005.06813.x","article-title":"Imatinib mesilate (Glivec): a systemic depigmenting agent for extensive vitiligo?","volume":"153","author":"Legros","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2008.06.029_bib37","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1002\/cncr.20267","article-title":"Imatinib mesylate causes hypopigmentation in the skin","volume":"100","author":"Leong","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2008.06.029_bib38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00043426-200403000-00016","article-title":"Hypopigmentation from imatinib mesylate (Gleevec)","volume":"26","author":"Grossman","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaad.2008.06.029_bib39","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/cncr.11812","article-title":"Imatinib mesylate causes hypopigmentation in the skin","volume":"98","author":"Tsao","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2008.06.029_bib40","first-page":"722","article-title":"Hypopigmentation in an African patient treated with imatinib mesylate: a case report","volume":"95","author":"Hasan","year":"2003","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.jaad.2008.06.029_bib41","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1468-3083.2006.01981.x","article-title":"A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients","volume":"21","author":"Brazzelli","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2008.06.029_bib42","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1200\/JCO.2002.20.3.869","article-title":"Challenges in oncology. Case 3. Depigmentation in a chronic myeloid leukemia patient treated with STI-571","volume":"20","author":"Raanani","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2008.06.029_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1523-1747.1998.00272.x","article-title":"The SCF\/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis","volume":"111","author":"Grichnik","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2008.06.029_bib44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MPH.0b013e318033a76c","article-title":"Imatinib-induced dental hyperpigmentation in childhood chronic myeloid leukemia","volume":"29","author":"Singh","year":"2007","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jaad.2008.06.029_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0378-6323.19727","article-title":"Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia","volume":"72","author":"Prabhash","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208007950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208007950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:09:36Z","timestamp":1759270176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962208007950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0190962208007950"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2008.06.029","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imatinib mesylate\u2013induced repigmentation of vitiligo lesions in a patient with recurrent gastrointestinal stromal tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2008.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}